| 9/6/2018 | HYLM | AMAG Pharmaceuticals redeems 7 7/8% notes via Cord Blood proceeds
|
| 6/18/2018 | BKCVHY | S&P puts AMAG on positive watch
|
| 6/15/2018 | HY | Market Commentary: PHI joins calendar, existing notes gain; MGM dominates; Ardent trades up; AMAG jumps
|
| 6/15/2018 | HYLM | AMAG Pharmaceuticals to repay 7 7/8% notes with Cord Blood proceeds
|
| 2/27/2018 | BKBWHY | AMAG has ‘high degree’ of flexibility, de-levers by 20% during 2017
|
| 2/15/2018 | HY | Market Commentary: Primary stays quiet, overall market firms; Bombardier up on Q4; funds plunge $6.3 billion
|
| 1/30/2018 | BKCVHY | S&P lowers AMAG, notes
|
| 5/12/2017 | BKCVHY | Moody’s raises AMAG notes to Ba3
|
| 5/8/2017 | BKCVHY | S&P affirms AMAG, lifts notes to BB-
|
| 2/21/2017 | BKCVHY | Moody’s revises AMAG view to stable
|
| 11/18/2015 | BKBWCVHY | AMAG Pharmaceuticals ends third quarter with $1.1 billion total debt
|
| 8/20/2015 | HY | Market Commentary: Morning Commentary: High-yield lower, but new issues maintain premiums; commodities under pressure
|
| 8/18/2015 | HY | Market Commentary: Oneok, Hill-Rom price; new Hill-Rom notes move up; market awaits oversubscribed KIK offering
|
| 8/13/2015 | HY | Market Commentary: No pricings; Oneok hits the road; new Post, AMAG issues firm smartly; funds lose $1.21 billion
|
| 8/13/2015 | CLHY | Market Commentary: Owens-Brockway Glass, Knowledge Universe, AMAG Pharmaceuticals, Vistage, USI free to trade
|
| 8/13/2015 | HY | Market Commentary: Morning Commentary: Junk tracks volatile crude oil prices; Post, AMAG bonds well bid in secondary
|
| 8/12/2015 | HY | Market Commentary: Post two-part megadeal, upsized AMAG Pharmaceuticals price, AMAG gains; broad market lower
|
| 8/12/2015 | CLHY | Market Commentary: Global Healthcare breaks; Getty Images declines; Multiple primary deals undergo revisions
|
| 8/12/2015 | HY | New Issue: AMAG Pharmaceuticals sells upsized $500 million 7 7/8% eight-year notes at par
|
| 8/12/2015 | HY | Market Commentary: Morning Commentary: Amid global stock rout, junk down ½ point; Owens-Illinois paper eyed
|
| 8/12/2015 | HY | AMAG ups offering to $500 million, talks eight-year notes to yield 7¾%-8%; pricing Wednesday
|
| 8/8/2015 | HY | Market Commentary: Junk primary ends $7 billion week on a quiet note; energy credits again slide as oil drops
|
| 8/7/2015 | HY | Market Commentary: Morning Commentary: High yield down a quarter point, ex-energy, but recent issues holding above par
|
| 8/5/2015 | HY | Market Commentary: Upsized First Data drive-by leads biggest primary day since June; new Party City jumps
|
| 8/5/2015 | BKCVHY | Moody’s rates AMAG loan Ba2, notes B3
|
| 8/5/2015 | HY | AMAG Pharmaceuticals on roadshow for $450 million eight-year notes
|
| 8/4/2015 | CLHY | Market Commentary: PODS, Garda break; Pharmaceutical Products, Emdeon revise deals; Graton accelerates deadline
|
| 7/30/2015 | CLHY | Market Commentary: Asurion, Hill-Rom, Ardent, PLZ, Mohegan break; Quality Distribution, Linxens revise deals
|
| 6/29/2015 | BKHY | AMAG plans new term loan and bonds for Cord Blood Registry purchase
|
| 11/12/2014 | CLHY | Market Commentary: AMAG, Panda Stonewall break; SeaWorld drops with earnings; WorldPay revises add-on loan
|
| 11/6/2014 | CLHY | Market Commentary: Norwegian Cruise Line breaks above OID; AMAG Pharmaceuticals, Essar changes surface
|
| 10/23/2014 | CLHY | Market Commentary: Hargray Communications breaks; Ocwen, Walter Investment improve; DTZ flexes higher
|
| 10/20/2014 | CLHY | Market Commentary: Platform Specialty, Arysta move around with acquisition news; Crown Holdings breaks atop OID
|
| 1/19/2010 | CVHY | AMAG Pharmaceuticals files automatic shelf to sell debt, stock
|
